肿瘤科指南

订阅

MedSci主页 / 所有栏目 / 肿瘤科指南

2018 ASCRS临床实践指南：肛门鳞状细胞癌（修订版）

2018-06-06 美国结肠和直肠外科医师学会 Dis Colon Rectum. 2018 Jul;61(7):755-774.

肛门鳞状细胞癌

2018年6月，美国结肠和直肠外科医师学会(ASCRS)发布了肛门鳞状细胞癌临床实践指南2018修订版。针对肛门鳞状细胞癌的诊断和治疗提供实践指导建议，主要建议内容涉及：治疗前评估，检测，复发疾病的治疗和转移性疾病的治疗。

中文标题：

2018 ASCRS临床实践指南：肛门鳞状细胞癌（修订版）

英文标题：

The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for Anal Squamous Cell Cancers (Revised 2018).

发布机构：

美国结肠和直肠外科医师学会

发布日期：

2018-06-06

简要介绍：

2018年6月，美国结肠和直肠外科医师学会(ASCRS)发布了肛门鳞状细胞癌临床实践指南2018修订版。针对肛门鳞状细胞癌的诊断和治疗提供实践指导建议，主要建议内容涉及：治疗前评估，检测，复发疾病的治疗和转移性疾病的治疗。 

拓展指南：与肛门癌相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2018 ASCRS临床实践指南：肛门鳞状细胞癌（修订版）)] GetToolGuiderByIdResponse(projectId=1, id=7187b1c0016023c3, title=2018 ASCRS临床实践指南：肛门鳞状细胞癌（修订版）, enTitle=The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for Anal Squamous Cell Cancers (Revised 2018)., guiderFrom=Dis Colon Rectum. 2018 Jul;61(7):755-774., authorId=null, author=, summary=2018年6月，美国结肠和直肠外科医师学会(ASCRS)发布了肛门鳞状细胞癌临床实践指南2018修订版。针对肛门鳞状细胞癌的诊断和治疗提供实践指导建议，主要建议内容涉及：治疗前评估，检测，复发疾病的治疗和转移性疾病的治疗。 , cover=, journalId=null, articlesId=null, associationId=463, associationName=美国结肠和直肠外科医师学会, associationIntro=美国结肠直肠癌的外科医生(ASCRS)学会是第一个对结肠直肠癌外科医生和其他外科的学会，她致力于推进科学与实践,缓解患者的治疗疾病和紊乱影响结肠、直肠和肛门疾病以及功能紊乱对患者的影响。已经有超过1000家学会的2600多个成员都认可了美国董事会结肠直肠癌的外科手术。, copyright=0, guiderPublishedTime=Wed Jun 06 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>2018年6月，美国结肠和直肠外科医师学会(ASCRS)发布了肛门鳞状细胞癌临床实践指南2018修订版。针对肛门鳞状细胞癌的诊断和治疗提供实践指导建议，主要建议内容涉及：治疗前评估，检测，复发疾病的治疗和转移性疾病的治疗。 </div> <div><br> </div>拓展指南：<strong>与<font color=red>肛门癌</font>相关指南：</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=822b31c00155e681" title="NCCN临床实践指南：肛门癌（2018.V1）" target=_blank>NCCN临床实践指南：肛门癌（2018.V1）</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=4aeb61c001a58350" title="2017 ACPGBI指南：结肠癌，直肠癌以及肛门癌的管理" target=_blank>2017 ACPGBI指南：结肠癌，直肠癌以及肛门癌的管理</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=3e2161c001a20821" title="NCCN临床实践指南：肛门癌（2017.V2）" target=_blank>NCCN临床实践指南：肛门癌（2017.V2）</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=552621c001a135e1" title="NCCN临床实践指南：肛门癌（2017.V1）（中文翻译版）" target=_blank>NCCN临床实践指南：肛门癌（2017.V1）（中文翻译版）</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=2ec101c00135202d" title="NCCN临床实践指南：肛门癌（2017.V1）" target=_blank>NCCN临床实践指南：肛门癌（2017.V1）</a></li> 更多信息请点击：<a href="http://www.medsci.cn/guideline/list.do?q=%E8%82%9B%E9%97%A8%E7%99%8C" target=_blank>有关肛门癌更多指南</a></ul>, tagList=[TagDto(tagId=56321, tagName=肛门鳞状细胞癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=76, categoryName=胃肠外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=1, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5462, appHits=70, showAppHits=0, pcHits=4347, showPcHits=1748, likes=115, shares=1, comments=4, approvalStatus=1, publishedTime=Tue Jun 12 21:14:59 CST 2018, publishedTimeString=2018-06-06, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Tue Jun 12 21:14:59 CST 2018, updatedBy=null, updatedName=null, updatedTime=Tue Jan 02 18:31:34 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 ASCRS临床实践指南：肛门鳞状细胞癌（修订版）)])
2018 ASCRS临床实践指南：肛门鳞状细胞癌（修订版）
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=323888, encodeId=ad24323888c1, content=认真学习.把间接经验应用到临床实践中去.然后再总结出新思路.给点赞啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Wed Jun 13 16:48:24 CST 2018, time=2018-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323727, encodeId=80b8323e27c5, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Wed Jun 13 06:07:12 CST 2018, time=2018-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323641, encodeId=fd1b32364185, content=不错的文章值得拥有哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Tue Jun 12 22:58:26 CST 2018, time=2018-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323635, encodeId=8b8232363515, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6r91EF8BMOLCD55MqUYf0ibGeibzcwCxaSD5XqTv5sRrxxzV9TpHfN8fDaNYCt8Jay98QLKHyzBpkr1f4v2EIcDQ/132, createdBy=c24466863, createdName=liuchuan1982, createdTime=Tue Jun 12 22:56:05 CST 2018, time=2018-06-12, status=1, ipAttribution=)]
    2018-06-13 虈亣靌

    认真学习.把间接经验应用到临床实践中去.然后再总结出新思路.给点赞啦

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=323888, encodeId=ad24323888c1, content=认真学习.把间接经验应用到临床实践中去.然后再总结出新思路.给点赞啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Wed Jun 13 16:48:24 CST 2018, time=2018-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323727, encodeId=80b8323e27c5, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Wed Jun 13 06:07:12 CST 2018, time=2018-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323641, encodeId=fd1b32364185, content=不错的文章值得拥有哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Tue Jun 12 22:58:26 CST 2018, time=2018-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323635, encodeId=8b8232363515, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6r91EF8BMOLCD55MqUYf0ibGeibzcwCxaSD5XqTv5sRrxxzV9TpHfN8fDaNYCt8Jay98QLKHyzBpkr1f4v2EIcDQ/132, createdBy=c24466863, createdName=liuchuan1982, createdTime=Tue Jun 12 22:56:05 CST 2018, time=2018-06-12, status=1, ipAttribution=)]
    2018-06-13 1209e435m98(暂无昵称)

    学习了.谢谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=323888, encodeId=ad24323888c1, content=认真学习.把间接经验应用到临床实践中去.然后再总结出新思路.给点赞啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Wed Jun 13 16:48:24 CST 2018, time=2018-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323727, encodeId=80b8323e27c5, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Wed Jun 13 06:07:12 CST 2018, time=2018-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323641, encodeId=fd1b32364185, content=不错的文章值得拥有哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Tue Jun 12 22:58:26 CST 2018, time=2018-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323635, encodeId=8b8232363515, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6r91EF8BMOLCD55MqUYf0ibGeibzcwCxaSD5XqTv5sRrxxzV9TpHfN8fDaNYCt8Jay98QLKHyzBpkr1f4v2EIcDQ/132, createdBy=c24466863, createdName=liuchuan1982, createdTime=Tue Jun 12 22:56:05 CST 2018, time=2018-06-12, status=1, ipAttribution=)]
    2018-06-12 1e1b8538m79(暂无匿称)

    不错的文章值得拥有哦

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=323888, encodeId=ad24323888c1, content=认真学习.把间接经验应用到临床实践中去.然后再总结出新思路.给点赞啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Wed Jun 13 16:48:24 CST 2018, time=2018-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323727, encodeId=80b8323e27c5, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Wed Jun 13 06:07:12 CST 2018, time=2018-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323641, encodeId=fd1b32364185, content=不错的文章值得拥有哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Tue Jun 12 22:58:26 CST 2018, time=2018-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323635, encodeId=8b8232363515, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6r91EF8BMOLCD55MqUYf0ibGeibzcwCxaSD5XqTv5sRrxxzV9TpHfN8fDaNYCt8Jay98QLKHyzBpkr1f4v2EIcDQ/132, createdBy=c24466863, createdName=liuchuan1982, createdTime=Tue Jun 12 22:56:05 CST 2018, time=2018-06-12, status=1, ipAttribution=)]
    2018-06-12 liuchuan1982

    好

    0